VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IHiHuman Inc.
$1.40$14M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIHBalance Sheet

iHuman Inc. (IH) Balance Sheet

8Y historyFree accessUpdated daily

The company maintains a robust liquidity profile with a current ratio of 3.55 and minimal debt, as evidenced by a debt-to-equity ratio of only 0.01.

IH Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets1.26B1.3B1.34B1.38B1.25B1.02B1.02B163.06M57.33M
Cash & Short-Term Investments1.1B1.15B1.17B1.21B1.05B855.36M861.68M104.88M6.12M
Cash Only605.14M1.15B1.12B1.21B1.05B855.36M861.68M104.88M6.12M
Short-Term Investments495M045.46M000000
Accounts Receivable57.77M51.42M54.08M62.64M81.9M58.98M78.29M20.98M13.62M
Days Sales Outstanding24.9523.2521.422.4630.3322.7953.7235.0337.71
Inventory20.66M21.4M23.48M16.52M19.13M28.05M16.87M20.66M29.63M
Days Inventory Outstanding25.7930.1130.3820.3123.7236.043789.62164.22
Other Current Assets85.22M74.53M69.2M72.5M102.77M72.85M64.62M14.09M7.64M
Total Non-Current Assets71.29M70.02M83.82M68.06M79.61M85.64M25.48M5.25M1.27M
Property, Plant & Equipment14.93M14.16M18.36M9.82M21.99M50.52M12.91M2.49M660K
Fixed Asset Turnover62.33x57.00x50.23x103.71x44.82x18.70x41.20x87.92x199.80x
Goodwill000000000
Intangible Assets14.92M17.65M16.43M23.25M24.87M27.29M11.79M103K136K
Long-Term Investments105.33M26.35M26.33M26.33M26.33M0000
Other Non-Current Assets15.11M11.87M22.7M8.66M6.42M7.83M784K2.66M478K
Total Assets1.34B1.37B1.42B1.45B1.33B1.1B1.05B168.31M58.6M
Asset Turnover0.64x0.59x0.65x0.70x0.74x0.86x0.51x1.30x2.25x
Asset Growth %-3.71%-3.55%-2.13%8.78%21.12%5.15%522.02%187.23%-
Total Current Liabilities355.69M364.21M447.54M490.76M561.05M482.93M399.22M182.76M122.33M
Accounts Payable21.2M25.1M30.23M22.14M24.21M30.54M21.55M10.3M13.13M
Days Payables Outstanding32.7635.3239.1227.2230.0239.2347.2544.6872.8
Short-Term Debt02.17M00000061.82M
Deferred Revenue (Current)791.18M220.05M283.25M318.59M379.06M302.98M268.61M71.83M28.15M
Other Current Liabilities0116.89M5.82M4.91M5.17M7.36M3.34M70.96M29.94M
Current Ratio3.55x3.57x2.98x2.82x2.23x2.10x2.56x0.89x0.47x
Quick Ratio3.49x3.51x2.93x2.78x2.20x2.04x2.52x0.78x0.23x
Cash Conversion Cycle17.9818.0512.6615.5524.0319.643.4679.97129.13
Total Non-Current Liabilities10.01M9.21M11.25M1.93M2.89M9.58M5.07M00
Long-Term Debt000000000
Capital Lease Obligations32.58M9.21M11.25M1.93M2.89M9.58M5.07M00
Deferred Tax Liabilities000000000
Other Non-Current Liabilities000000000
Total Liabilities365.7M373.42M458.8M492.69M563.95M492.51M404.29M182.76M122.33M
Total Debt12.28M11.38M14.91M3.86M9.02M34.25M6.61M061.82M
Net Debt-592.86M-1.14B-1.11B-1.21B-1.04B-821.12M-855.07M-104.88M55.7M
Debt / Equity0.01x0.01x0.02x0.00x0.01x0.06x0.01x--
Debt / EBITDA0.10x0.15x0.17x0.02x0.07x----
Net Debt / EBITDA-4.95x-15.31x-12.95x-7.05x-8.50x----
Interest Coverage---------
Total Equity969.39M995.8M960.85M957.8M769.45M608.37M642.65M-14.45M-63.73M
Equity Growth %13%3.64%0.32%24.48%26.48%-5.33%4547.73%77.33%-
Book Value per Share90.6393.0388.5787.4771.1957.0470.98-1.35-5.98
Total Shareholders' Equity969.39M995.8M960.85M957.8M769.45M608.37M642.65M-14.45M-63.73M
Common Stock185K186.12K185K185K185K185K184K158K111K
Retained Earnings16.3M53.26M-42.1M-140.46M-321.17M-423.02M-385.97M-348.5M-72.9M
Treasury Stock-38.12M-43.51M-26.3M-16.66M-7.12M-164K000
Accumulated OCI30.85M24.61M32.4M26.12M18.46M-34.68M-21.86M0-532K
Minority Interest000000000

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Capital deployment and demographic headwinds

Balance Sheet Stability Amid Contraction

As reported in recent financial filings, iHuman maintains a fortress-like balance sheet with total assets of $1.3 billion, yet the persistent decline in retained earnings suggests that the company's core operational trajectory remains challenged by broader market saturation and demographic headwinds in the Chinese education sector.

The company's ability to preserve its asset base despite revenue contraction highlights a conservative financial posture. However, the ongoing erosion of retained earnings indicates that the business model is struggling to generate sufficient organic growth to offset its fixed cost structure.

Excessive Liquidity and Deployment Uncertainty

Based on the latest quarterly data, iHuman holds a substantial cash position of $605.1 million, which, while providing a robust current ratio of 3.55, raises questions regarding management's inability to effectively deploy this capital to reverse the company's current top-line revenue decline.

The high liquidity buffer serves as a significant safety net against regulatory or market shocks, yet it also acts as a drag on return on equity. Investors should monitor whether this cash pile remains idle or if management eventually pivots toward more aggressive capital allocation strategies.

Deferred Revenue Trends Signal Weakness

According to historical balance sheet disclosures, deferred revenue has trended downward to $240.0 million in 2025Q2, which serves as a leading indicator of potential future revenue weakness and suggests that the company's subscription-based model is facing increasing pressure from a shrinking addressable market.

The decline in unearned revenue suggests that new subscription intake is failing to keep pace with the recognition of existing contracts. This trend warrants further investigation into whether the company's edutainment offerings are losing their competitive edge in the domestic Chinese market.

Equity Quality and Retained Earnings

As indicated by the company's financial statements, the shift in retained earnings from a deep deficit of $267.5 million in 2023Q1 to a positive $16.3 million in 2025Q2 reflects a significant accounting turnaround, though this improvement appears largely disconnected from the company's underlying operational growth.

The improvement in equity quality is a positive development, yet it may be influenced by non-operating factors rather than core business expansion. Analysts should remain cautious about the sustainability of this trend given the ongoing revenue contraction and the lack of clear catalysts for future growth.

IH — Frequently Asked Questions

Quick answers to the most common questions about buying IH stock.

What are the total assets of iHuman Inc. (IH)?

As of 2025, iHuman Inc. (IH) had total assets of $1.37B including $1.30B in current assets.

How much debt does iHuman Inc. (IH) have?

iHuman Inc. (IH) carries total debt of $11.4M, offset by $1.15B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of iHuman Inc.?

iHuman Inc. (IH) has total shareholders' equity (book value) of $995.8M ($93.03 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is iHuman Inc.'s current ratio and liquidity?

iHuman Inc. (IH) reported a current ratio of 3.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.